{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:40:03Z","timestamp":1718239203953},"reference-count":131,"publisher":"Elsevier","isbn-type":[{"value":"9780128018996","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/b978-0-12-801899-6.00014-0","type":"book-chapter","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T20:29:36Z","timestamp":1449865776000},"page":"275-296","source":"Crossref","is-referenced-by-count":1,"title":["DNA Methylation Alterations as Biomarkers for Prostate Cancer"],"prefix":"10.1016","author":[{"given":"Jo\u00e3o","family":"Ramalho-Carvalho","sequence":"first","affiliation":[]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/B978-0-12-801899-6.00014-0_bib1","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMcp1103642","article-title":"Clinical practice. Screening for prostate cancer","volume":"365","author":"Hoffman","year":"2011","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/B978-0-12-801899-6.00014-0_bib2","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1101\/gad.1965810","article-title":"Molecular genetics of prostate cancer: new prospects for old challenges","volume":"24","author":"Shen","year":"2010","journal-title":"Genes Dev"},{"issue":"9","key":"10.1016\/B978-0-12-801899-6.00014-0_bib3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00428-008-0707-5","article-title":"Precursor lesions to prostatic adenocarcinoma","volume":"454","author":"Epstein","year":"2009","journal-title":"Virchows Archiv"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cell.2013.03.021","article-title":"Punctuated evolution of prostate cancer genomes","volume":"153","author":"Baca","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1158\/1078-0432.CCR-12-1452","article-title":"New strategies in prostate cancer: translating genomics into the clinic","volume":"19","author":"Beltran","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib7","doi-asserted-by":"crossref","first-page":"400.e1","DOI":"10.1016\/j.ccr.2013.08.033","article-title":"SnapShot: prostate cancer","volume":"24","author":"Barlow","year":"2013","journal-title":"Cancer Cell"},{"issue":"49","key":"10.1016\/B978-0-12-801899-6.00014-0_bib8","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1038\/onc.2013.206","article-title":"Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches","volume":"32","author":"Karantanos","year":"2013","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/B978-0-12-801899-6.00014-0_bib9","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1373\/clinchem.2011.165977","article-title":"Molecular alterations during progression of prostate cancer to androgen independence","volume":"57","author":"Saraon","year":"2011","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/B978-0-12-801899-6.00014-0_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/B978-0-12-801899-6.00014-0_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-157-2-201207170-00463","article-title":"What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation","volume":"157","author":"Catalona","year":"2012","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ije\/dyr184","article-title":"The epigenotype. 1942","volume":"41","author":"Waddington","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/B978-0-12-801899-6.00014-0_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/B978-0-12-801899-6.00014-0_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"issue":"11","key":"10.1016\/B978-0-12-801899-6.00014-0_bib15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/B978-0-12-801899-6.00014-0_bib16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrg3772","article-title":"Advances in the profiling of DNA modifications: cytosine methylation and beyond","volume":"15","author":"Plongthongkum","year":"2014","journal-title":"Nat Rev Genet"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrg2732","article-title":"Principles and challenges of genomewide DNA methylation analysis","volume":"11","author":"Laird","year":"2010","journal-title":"Nat Rev Genet"},{"issue":"10","key":"10.1016\/B978-0-12-801899-6.00014-0_bib18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/B978-0-12-801899-6.00014-0_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nsmb.1594","article-title":"Developmental programming of CpG island methylation profiles in the human genome","volume":"16","author":"Straussman","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"10.1016\/B978-0-12-801899-6.00014-0_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat Rev Genet"},{"issue":"12","key":"10.1016\/B978-0-12-801899-6.00014-0_bib21","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/sj.bjc.6604374","article-title":"Proteins that bind methylated DNA and human cancer: reading the wrong words","volume":"98","author":"Lopez-Serra","year":"2008","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/B978-0-12-801899-6.00014-0_bib22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","article-title":"Epigenetics: a landscape takes shape","volume":"128","author":"Goldberg","year":"2007","journal-title":"Cell"},{"issue":"7","key":"10.1016\/B978-0-12-801899-6.00014-0_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/embor.2011.110","article-title":"Regulation of mammalian DNA methyltransferases: a route to new mechanisms","volume":"12","author":"Denis","year":"2011","journal-title":"EMBO Rep"},{"issue":"5759","key":"10.1016\/B978-0-12-801899-6.00014-0_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.1120976","article-title":"Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2","volume":"311","author":"Goll","year":"2006","journal-title":"Science"},{"key":"10.1016\/B978-0-12-801899-6.00014-0_bib25","article-title":"Prostate cancer epigenetic biomarkers: next-generation technologies","author":"Valdes-Mora","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.2836","article-title":"Large conserved domains of low DNA methylation maintained by Dnmt3a","volume":"46","author":"Jeong","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/B978-0-12-801899-6.00014-0_bib27","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.cell.2013.04.022","article-title":"Epigenomic analysis of multilineage differentiation of human embryonic stem cells","volume":"153","author":"Xie","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/B978-0-12-801899-6.00014-0_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/bjc.2011.550","article-title":"Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research","volume":"106","author":"Shenker","year":"2012","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ng1929","article-title":"Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription","volume":"39","author":"Zilberman","year":"2007","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/B978-0-12-801899-6.00014-0_bib30","doi-asserted-by":"crossref","first-page":"e6953","DOI":"10.1371\/journal.pone.0006953","article-title":"Insulin gene expression is regulated by DNA methylation","volume":"4","author":"Kuroda","year":"2009","journal-title":"PLoS One"},{"issue":"7291","key":"10.1016\/B978-0-12-801899-6.00014-0_bib31","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/nature08924","article-title":"CpG islands influence chromatin structure via the CpG-binding protein Cfp1","volume":"464","author":"Thomson","year":"2010","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-801899-6.00014-0_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrrev.2008.02.004","article-title":"Epigenetic interplay between histone modifications and DNA methylation in gene silencing","volume":"659","author":"Vaissiere","year":"2008","journal-title":"Mutat Res"},{"issue":"2","key":"10.1016\/B978-0-12-801899-6.00014-0_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ng.298","article-title":"The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores","volume":"41","author":"Irizarry","year":"2009","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/B978-0-12-801899-6.00014-0_bib34","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/ng.471","article-title":"Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts","volume":"41","author":"Doi","year":"2009","journal-title":"Nat Genet"},{"issue":"7313","key":"10.1016\/B978-0-12-801899-6.00014-0_bib35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature09367","article-title":"Comprehensive methylome map of lineage commitment from haematopoietic progenitors","volume":"467","author":"Ji","year":"2010","journal-title":"Nature"},{"issue":"12","key":"10.1016\/B978-0-12-801899-6.00014-0_bib36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrurol.2010.185","article-title":"The epigenome as a therapeutic target in prostate cancer","volume":"7","author":"Perry","year":"2010","journal-title":"Nat Rev Urol"},{"issue":"6","key":"10.1016\/B978-0-12-801899-6.00014-0_bib37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrg3722","article-title":"The rise of regulatory RNA","volume":"15","author":"Morris","year":"2014","journal-title":"Nat Rev Genet"},{"issue":"13","key":"10.1016\/B978-0-12-801899-6.00014-0_bib38","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/onc.2011.354","article-title":"DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer","volume":"31","author":"Lopez-Serra","year":"2012","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/B978-0-12-801899-6.00014-0_bib39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/B978-0-12-801899-6.00014-0_bib40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.eururo.2011.06.035","article-title":"Epigenetics in prostate cancer: biologic and clinical relevance","volume":"60","author":"Jeronimo","year":"2011","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/B978-0-12-801899-6.00014-0_bib41","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1210\/en.2009-0573","article-title":"Epigenetic alterations in human prostate cancers","volume":"150","author":"Nelson","year":"2009","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib42","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.celrep.2014.06.053","article-title":"Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer","volume":"8","author":"Brocks","year":"2014","journal-title":"Cell Rep"},{"issue":"169","key":"10.1016\/B978-0-12-801899-6.00014-0_bib43","doi-asserted-by":"crossref","first-page":"169ra10","DOI":"10.1126\/scitranslmed.3005211","article-title":"DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases","volume":"5","author":"Aryee","year":"2013","journal-title":"Sci Transl Med"},{"issue":"9360","key":"10.1016\/B978-0-12-801899-6.00014-0_bib44","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(03)12713-4","article-title":"Prostate cancer epidemiology","volume":"361","author":"Gronberg","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/B978-0-12-801899-6.00014-0_bib45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bbrc.2004.06.164","article-title":"Age-dependent methylation of ESR1 gene in prostate cancer","volume":"321","author":"Li","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/B978-0-12-801899-6.00014-0_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jnci\/dji010","article-title":"Epigenetic changes in prostate cancer: implication for diagnosis and treatment","volume":"97","author":"Li","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"10.1016\/B978-0-12-801899-6.00014-0_bib47","first-page":"5310","article-title":"Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells","volume":"58","author":"Jarrard","year":"1998","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/B978-0-12-801899-6.00014-0_bib48","first-page":"3623","article-title":"Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer","volume":"60","author":"Kinoshita","year":"2000","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/B978-0-12-801899-6.00014-0_bib49","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/labinvest.3780190","article-title":"Epigenetic regulation of androgen receptor gene expression in human prostate cancers","volume":"80","author":"Nakayama","year":"2000","journal-title":"Lab Invest"},{"issue":"2A","key":"10.1016\/B978-0-12-801899-6.00014-0_bib50","first-page":"1285","article-title":"5,6 Dihydro-5\u2019-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells","volume":"19","author":"Izbicka","year":"1999","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib51","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<356::AID-PATH863>3.0.CO;2-U","article-title":"Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors","volume":"182","author":"Hobisch","year":"1997","journal-title":"J Pathol"},{"issue":"14","key":"10.1016\/B978-0-12-801899-6.00014-0_bib52","first-page":"5331","article-title":"Frequent loss of estrogen receptor-beta expression in prostate cancer","volume":"61","author":"Horvath","year":"2001","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib53","first-page":"702","article-title":"Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression","volume":"60","author":"Li","year":"2000","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/B978-0-12-801899-6.00014-0_bib54","first-page":"3175","article-title":"Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation","volume":"60","author":"Lau","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0002-9440(10)61676-8","article-title":"Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma","volume":"159","author":"Leav","year":"2001","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/B978-0-12-801899-6.00014-0_bib56","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0002-9440(10)63760-1","article-title":"Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis","volume":"164","author":"Zhu","year":"2004","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1097-0045(20000515)43:3<233::AID-PROS10>3.0.CO;2-S","article-title":"Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers","volume":"43","author":"Nguyen","year":"2000","journal-title":"Prostate"},{"issue":"11","key":"10.1016\/B978-0-12-801899-6.00014-0_bib58","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00109-006-0099-4","article-title":"Hypermethylation of cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer","volume":"84","author":"Henrique","year":"2006","journal-title":"J Mol Med Berl"},{"issue":"4","key":"10.1016\/B978-0-12-801899-6.00014-0_bib59","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/dna.2005.24.264","article-title":"Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions","volume":"24","author":"Henrique","year":"2005","journal-title":"DNA Cell Biol"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib60","first-page":"35","article-title":"Methylation of the 5\u2032 CpG island of the endothelin B receptor gene is common in human prostate cancer","volume":"57","author":"Nelson","year":"1997","journal-title":"Cancer Res"},{"issue":"44","key":"10.1016\/B978-0-12-801899-6.00014-0_bib61","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1038\/sj.onc.1205814","article-title":"Frequent hypermethylation of the RASSF1A gene in prostate cancer","volume":"21","author":"Liu","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jcp.56.1.52","article-title":"Endothelin B receptor gene hypermethylation in prostate adenocarcinoma","volume":"56","author":"Jeronimo","year":"2003","journal-title":"J Clin Pathol"},{"issue":"24","key":"10.1016\/B978-0-12-801899-6.00014-0_bib63","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1158\/1078-0432.CCR-04-0894","article-title":"A quantitative promoter methylation profile of prostate cancer","volume":"10","author":"Jeronimo","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/B978-0-12-801899-6.00014-0_bib64","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-5347(05)66047-8","article-title":"Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer","volume":"166","author":"Li","year":"2001","journal-title":"J Urol"},{"issue":"22","key":"10.1016\/B978-0-12-801899-6.00014-0_bib65","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/jnci\/93.22.1747","article-title":"Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma","volume":"93","author":"Jeronimo","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/B978-0-12-801899-6.00014-0_bib66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/path.1503","article-title":"Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia","volume":"202","author":"Kang","year":"2004","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1541-7786.MCR-05-0113","article-title":"Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis","volume":"4","author":"Henrique","year":"2006","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/ERC-07-0208","article-title":"The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer","volume":"15","author":"Murphy","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/B978-0-12-801899-6.00014-0_bib69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1476-4598-5-28","article-title":"Methylation mediated silencing of TMS1\/ASC gene in prostate cancer","volume":"5","author":"Das","year":"2006","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/B978-0-12-801899-6.00014-0_bib70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2005.11.002","article-title":"Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer","volume":"242","author":"Suzuki","year":"2006","journal-title":"Cancer Lett"},{"issue":"8","key":"10.1016\/B978-0-12-801899-6.00014-0_bib71","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s10495-010-0508-6","article-title":"Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer","volume":"15","author":"Carvalho","year":"2010","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/B978-0-12-801899-6.00014-0_bib72","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.eururo.2011.01.044","article-title":"MicroRNA in prostate, bladder, and kidney cancer: a systematic review","volume":"59","author":"Catto","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/B978-0-12-801899-6.00014-0_bib73","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2164-12-54","article-title":"Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription","volume":"12","author":"Hulf","year":"2011","journal-title":"BMC Genomics"},{"issue":"46","key":"10.1016\/B978-0-12-801899-6.00014-0_bib74","first-page":"212","article-title":"Emerging role of microRNAs in prostate cancer: implications for personalized medicine","volume":"9","author":"Gandellini","year":"2010","journal-title":"Discov Med"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/onc.2012.14","article-title":"DNA methylation silences miR-132 in prostate cancer","volume":"32","author":"Formosa","year":"2013","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/B978-0-12-801899-6.00014-0_bib76","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/carcin\/bgr036","article-title":"MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer","volume":"32","author":"Suh","year":"2011","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00428-008-0706-6","article-title":"Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm","volume":"454","author":"Cho","year":"2009","journal-title":"Virchows Archiv"},{"issue":"21","key":"10.1016\/B978-0-12-801899-6.00014-0_bib78","doi-asserted-by":"crossref","first-page":"8954","DOI":"10.1158\/0008-5472.CAN-07-6088","article-title":"DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity","volume":"68","author":"Yegnasubramanian","year":"2008","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cancergencyto.2004.04.004","article-title":"Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome?","volume":"156","author":"Brothman","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib80","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/gcc.10092","article-title":"Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma","volume":"35","author":"Schulz","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"issue":"5618","key":"10.1016\/B978-0-12-801899-6.00014-0_bib81","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.1083557","article-title":"Chromosomal instability and tumors promoted by DNA hypomethylation","volume":"300","author":"Eden","year":"2003","journal-title":"Science"},{"issue":"20","key":"10.1016\/B978-0-12-801899-6.00014-0_bib82","first-page":"5274","article-title":"Hypomethylation of DNA in pathological conditions of the human prostate","volume":"47","author":"Bedford","year":"1987","journal-title":"Cancer Res"},{"issue":"54","key":"10.1016\/B978-0-12-801899-6.00014-0_bib83","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.1038\/sj.onc.1208137","article-title":"Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis","volume":"23","author":"Chalitchagorn","year":"2004","journal-title":"Oncogene"},{"issue":"48","key":"10.1016\/B978-0-12-801899-6.00014-0_bib84","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1038\/sj.onc.1208866","article-title":"Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense\/antisense transcription and marks the progression of chronic myeloid leukemia","volume":"24","author":"Roman-Gomez","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib85","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0006-291X(03)01121-5","article-title":"Promoter hypomethylation of a novel cancer\/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma","volume":"307","author":"Cho","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"10.1016\/B978-0-12-801899-6.00014-0_bib86","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1158\/1078-0432.CCR-04-2545","article-title":"Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer","volume":"11","author":"Tokizane","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib87","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1078-0432.1028.11.3","article-title":"Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer","volume":"11","author":"Ogishima","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/B978-0-12-801899-6.00014-0_bib88","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1096\/fj.02-0973com","article-title":"Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in\u00a0vitro and in\u00a0vivo","volume":"17","author":"Pakneshan","year":"2003","journal-title":"Faseb J"},{"issue":"45","key":"10.1016\/B978-0-12-801899-6.00014-0_bib89","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1038\/sj.onc.1210472","article-title":"Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer","volume":"26","author":"Wang","year":"2007","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/B978-0-12-801899-6.00014-0_bib90","first-page":"1471","article-title":"Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues","volume":"1","author":"Jarrard","year":"1995","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/B978-0-12-801899-6.00014-0_bib91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3727\/096504005776404607","article-title":"Hypomethylation of the XIST gene promoter in prostate cancer","volume":"15","author":"Laner","year":"2005","journal-title":"Oncol Res"},{"issue":"4","key":"10.1016\/B978-0-12-801899-6.00014-0_bib92","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1158\/1541-7786.MCR-08-0400","article-title":"Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP","volume":"7","author":"Karpf","year":"2009","journal-title":"Mol Cancer Res"},{"issue":"6097","key":"10.1016\/B978-0-12-801899-6.00014-0_bib93","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1222077","article-title":"Landscape of somatic retrotransposition in human cancers","volume":"337","author":"Lee","year":"2012","journal-title":"Science"},{"issue":"2","key":"10.1016\/B978-0-12-801899-6.00014-0_bib94","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.canlet.2011.12.026","article-title":"Epigenetic biomarkers in urological tumors: a systematic review","volume":"342","author":"Jeronimo","year":"2014","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/B978-0-12-801899-6.00014-0_bib95","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.eururo.2004.06.014","article-title":"Molecular detection of prostate cancer: a role for GSTP1 hypermethylation","volume":"46","author":"Henrique","year":"2004","journal-title":"Eur Urol"},{"issue":"21","key":"10.1016\/B978-0-12-801899-6.00014-0_bib96","first-page":"5941","article-title":"Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids","volume":"60","author":"Goessl","year":"2000","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0090-4295(01)01268-7","article-title":"DNA-based detection of prostate cancer in urine after prostatic massage","volume":"58","author":"Goessl","year":"2001","journal-title":"Urology"},{"issue":"9","key":"10.1016\/B978-0-12-801899-6.00014-0_bib98","first-page":"2727","article-title":"Molecular detection of prostate cancer in urine by GSTP1 hypermethylation","volume":"7","author":"Cairns","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/B978-0-12-801899-6.00014-0_bib99","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0090-4295(02)01949-0","article-title":"Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer","volume":"60","author":"Jer\u00f3nimo","year":"2002","journal-title":"Urology"},{"issue":"7","key":"10.1016\/B978-0-12-801899-6.00014-0_bib100","first-page":"2673","article-title":"Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens","volume":"9","author":"Gonzalgo","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"27","key":"10.1016\/B978-0-12-801899-6.00014-0_bib101","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1200\/JCO.2005.07.009","article-title":"Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects","volume":"23","author":"Hoque","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/B978-0-12-801899-6.00014-0_bib102","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1158\/1078-0432.CCR-06-2467","article-title":"Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage","volume":"13","author":"Roupret","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/pros.20651","article-title":"CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer","volume":"68","author":"Ellinger","year":"2008","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/B978-0-12-801899-6.00014-0_bib104","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.juro.2011.06.052","article-title":"Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0ng\/ml using an investigational prostate cancer methylation assay","volume":"186","author":"Baden","year":"2011","journal-title":"J Urol"},{"issue":"11","key":"10.1016\/B978-0-12-801899-6.00014-0_bib105","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/jcmm.12394","article-title":"Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential","volume":"18","author":"Almeida","year":"2014","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/B978-0-12-801899-6.00014-0_bib106","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/bjc.2014.337","article-title":"DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy","volume":"111","author":"Paziewska","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/B978-0-12-801899-6.00014-0_bib107","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1038\/srep04432","article-title":"Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids","volume":"4","author":"Olkhov-Mitsel","year":"2014","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/B978-0-12-801899-6.00014-0_bib108","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.juro.2014.04.013","article-title":"Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies","volume":"192","author":"Partin","year":"2014","journal-title":"J Urol"},{"issue":"26","key":"10.1016\/B978-0-12-801899-6.00014-0_bib109","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1200\/JCO.2012.47.1847","article-title":"DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer","volume":"31","author":"Haldrup","year":"2013","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/B978-0-12-801899-6.00014-0_bib110","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1158\/0008-5472.CAN-03-3972","article-title":"Hypermethylation of CpG islands in primary and metastatic human prostate cancer","volume":"64","author":"Yegnasubramanian","year":"2004","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/B978-0-12-801899-6.00014-0_bib111","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-05-0658","article-title":"Multigene methylation analysis for detection and staging of prostate cancer","volume":"11","author":"Enokida","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/B978-0-12-801899-6.00014-0_bib112","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1158\/1078-0432.CCR-04-2446","article-title":"Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy","volume":"11","author":"Bastian","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/B978-0-12-801899-6.00014-0_bib113","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4161\/epi.1.4.3530","article-title":"CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized disease","volume":"1","author":"Woodson","year":"2006","journal-title":"Epigenetics"},{"issue":"5","key":"10.1016\/B978-0-12-801899-6.00014-0_bib114","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.juro.2007.01.010","article-title":"Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis","volume":"177","author":"Cottrell","year":"2007","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/B978-0-12-801899-6.00014-0_bib115","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.juro.2008.11.120","article-title":"DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy","volume":"181","author":"Weiss","year":"2009","journal-title":"J Urol"},{"issue":"23","key":"10.1016\/B978-0-12-801899-6.00014-0_bib116","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1158\/1078-0432.CCR-05-1183","article-title":"Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy","volume":"11","author":"Rosenbaum","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"20","key":"10.1016\/B978-0-12-801899-6.00014-0_bib117","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1158\/1078-0432.CCR-07-1042","article-title":"High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients","volume":"13","author":"Henrique","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/B978-0-12-801899-6.00014-0_bib118","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1158\/1078-0432.CCR-13-2642","article-title":"Hypermethylation of the GABRE\u223cmiR-452\u223cmiR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy","volume":"20","author":"Kristensen","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/B978-0-12-801899-6.00014-0_bib119","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/labinvest.2010.57","article-title":"DNA methylation of HOXD3 as a marker of prostate cancer progression","volume":"90","author":"Kron","year":"2010","journal-title":"Lab Invest"},{"issue":"23","key":"10.1016\/B978-0-12-801899-6.00014-0_bib120","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1038\/onc.2012.300","article-title":"Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer","volume":"32","author":"Hulf","year":"2013","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/B978-0-12-801899-6.00014-0_bib121","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/bjc.2014.463","article-title":"Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer","volume":"111","author":"Mahon","year":"2014","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/B978-0-12-801899-6.00014-0_bib122","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1093\/nar\/gkr1222","article-title":"MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer","volume":"40","author":"Hudson","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"10.1016\/B978-0-12-801899-6.00014-0_bib123","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4161\/cc.7.16.6533","article-title":"Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer","volume":"7","author":"Lodygin","year":"2008","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib124","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2008.12.098","article-title":"Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells","volume":"379","author":"Saito","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib125","doi-asserted-by":"crossref","first-page":"e8697","DOI":"10.1371\/journal.pone.0008697","article-title":"Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells","volume":"5","author":"Vrba","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/B978-0-12-801899-6.00014-0_bib126","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.bjc.6605742","article-title":"The functional significance of microRNA-145 in prostate cancer","volume":"103","author":"Zaman","year":"2010","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/B978-0-12-801899-6.00014-0_bib127","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/ijc.25162","article-title":"miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer","volume":"127","author":"Rauhala","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/B978-0-12-801899-6.00014-0_bib128","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1038\/cddis.2010.85","article-title":"Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells","volume":"1","author":"Bhatnagar","year":"2010","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/B978-0-12-801899-6.00014-0_bib129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.juro.2010.03.012","article-title":"Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer","volume":"184","author":"Banez","year":"2010","journal-title":"J Urol"},{"issue":"15","key":"10.1016\/B978-0-12-801899-6.00014-0_bib130","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/pros.21379","article-title":"Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer","volume":"71","author":"Bhusari","year":"2011","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/B978-0-12-801899-6.00014-0_bib131","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1158\/0008-5472.CAN-12-2968","article-title":"Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression","volume":"73","author":"Lin","year":"2013","journal-title":"Cancer Res"}],"container-title":["Epigenetic Biomarkers and Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128018996000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128018996000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:17:55Z","timestamp":1718237875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128018996000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780128018996"],"references-count":131,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-801899-6.00014-0","relation":{},"subject":[],"published":{"date-parts":[[2016]]}}}